查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2006200

兽医眼科护理市场：2026-2032年全球市场预测（按动物类型、产品类型、分销管道和最终用户划分）

Veterinary Eye Care Market by Animal Type, Product Type, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，兽医眼科护理市场价值将达到 50.1 亿美元，到 2026 年将成长至 53.7 亿美元，到 2032 年将达到 83.4 亿美元，复合年增长率为 7.53%。

主要市场统计数据
基准年 2025 50.1亿美元
预计年份：2026年 53.7亿美元
预测年份 2032 83.4亿美元
复合年增长率 (%) 7.53%

展望兽医眼科护理的未来，涵盖临床进步、技术进步和商业性变革，这些进步正在重塑兽医和患者的治疗结果。

由于临床、技术和商业性因素的相互作用，兽医眼科领域正处于转折点。影像学和就地检验的进步提高了伴侣动物和生产动物眼科评估的标准，而治疗方法的创新则改进了感染控制、发炎管理和慢性眼部润滑的方法。同时，不断变化的商业环境和饲主的期望也推动了诊所和医院对更高品质眼科护理的需求，迫使医疗机构重新评估其服务内容和资金配置。

对推动兽医眼科护理的变革性变化进行了清晰的总结，包括在整个生态系统中诊断的去中心化、标靶化的治疗以及渠道的现代化。

兽医眼科护理领域正经历着一场变革性的转变，这场变革超越了单纯的产品改进，涵盖了全新的护理模式和跨学科合作。携带式影像设备和简化的解读工具等诊断技术的进步，使得诊疗重点从集中式的专科机构转移到了基层医疗机构，从而实现了早期发现和微创干预。这种转变促使临床角色重新定义，全科医师越来越多地参与到以往由专科医师诊治的疾病中，改变了转诊模式和服务的经济模式。

分析概述了近期累积关税措施如何重塑兽医眼科供应链的供应韧性、采购行为和成本动态。

对眼科器械和药品活性成分进口产品征收关税，对兽医眼科领域的供应链、价格趋势和筹资策略产生了累积影响。关税带来的成本压力促使许多製造商和经销商重新评估其筹资策略，并强调供应商多元化和改善库存管理，以减少对特定贸易路线的依赖。因此，某些诊断设备和特殊治疗药物的前置作业时间和成本波动性增加，进而影响了诊所和医院的采购行为。

透过复杂的細項分析，将动物物种、产品类型、销售管道偏好和最终用户需求连结起来，揭示差异化的进入路径和商业性重点。

深入的市场区隔揭示了不同动物种类、产品类型、通路和终端用户环境下的需求模式、产品偏好和分销方式的差异。猫狗的需求主要集中在兽医诊断设备和眼科治疗药物上，这反映了饲主愿意投资先进的医疗照护。而牛的需求则更为独特，它们需要强大、便于现场使用的诊断设备，以及根据其生产和性能特点量身定制的、经济高效的治疗方法。产品类型细分也突显了诊断设备的普及取决于便携性和影像解析度之间的平衡，外科手术设备的投资反映了兽医病例的组成和手术量，以及治疗药物（分为抗感染药、抗发炎药和眼科润滑剂）的选择取决于物种特异性的药理特性和给药的便捷性。

影响美洲、欧洲、中东和非洲以及亚太地区市场采用速度、监管复杂性和分销管道有效性的关键区域趋势。

区域趋势决定了创新技术首先在何处得到应用，管理体制如何影响产品註册，以及哪些分销模式最为有效。在美洲，伴侣动物医学领域的临床应用十分活跃，这得益于成熟的兽医院网路以及对先进诊断技术和专科疗法的重视。供应链的柔软性和与经销商的成熟关係也促进了产品的快速推广。相较之下，欧洲、中东和非洲（EMEA）的情况则较为复杂，由于监管差异和分销管道分散，区域合作伙伴面临挑战和机会。在该地区取得成功取决于尊重当地监管专业知识和国家兽医实践的在地化商业策略。

这种企业级策略洞察揭示了产品创新、临床支援和供应链韧性如何推动兽医眼科护理领域的竞争优势和伙伴关係主导的成长。

在兽医眼科领域，产品卓越性、服务能力和合作伙伴关係关係之间的交会点正日益成为竞争格局的关键。主要企业透过投资提高诊断准确性、以用户为中心的设备人体工学设计以及针对不同物种剂量和耐受性差异的配方，脱颖而出。除了产品特性之外，那些能够提供完善的临床教育、快速技术支援和整合数位化资源的企业也越来越受到兽医的青睐，因为他们既追求治疗效果，也注重易用性。医疗设备製造商、药品研发商和分销网络之间的策略伙伴关係正在成为建立整合式医疗路径的关键机制，这些路径能够加速产品应用，简化采购和临床工作流程。

为相关人员提供切实可行的策略建议，以加强临床参与、实现供应链多元化和协调商业化，从而实现永续推广和竞争优势。

致力于在兽医眼科领域创造价值的产业领导者应采取多管齐下的策略，平衡产品创新、切实可行的商业化和业务永续营运。首先，他们应深化与临床实践的合作，透过创建转化证据和投资于能够显着提升诊断准确性、手术效果和治疗依从性的实用培训计画来实现这一目标。其次，他们应透过采购和物流多元化来降低对特定贸易路线的依赖，并考虑本地化生产和合约生产，从而提高响应速度并减少跨境摩擦。第三，他们应优化应对力，根据诊所、医院和研究机构的具体需求客製化产品组合和定价，确保产品既符合临床工作流程又符合采购週期。

对混合方法研究途径进行透明的解释，该方法整合了从业者访谈、技术审查和跨领域分析，以提供可操作的见解。

本研究结合了对临床医生、采购经理和技术供应商的初步访谈，以及对同行评审文献、监管指南和公开可用的诊断和治疗产品技术性能数据的系统性回顾。主要调查方法包括对代表性的诊所和医院进行结构化访谈，以了解临床医生的工作流程、采购限制和推广障碍，并透过与分销合作伙伴的讨论评估物流和通路经济效益。辅助研究着重于技术检验研究、製剂概况和监管申报，以确保产品层面的见解是基于已确立的临床和技术证据。

一项权威的综合分析强调了在兽医眼科护理中，将创新、临床检验和营运韧性相结合以改善结果所面临的策略挑战。

兽医眼科护理正朝着更一体化、主导的领域发展，诊断、治疗和护理模式相互融合，旨在改善所有物种的治疗效果。对临床需求、技术进步和不断变化的贸易趋势的全面分析表明，投资于临床检验、经销伙伴和供应链韧性的机构将获得长期成功。同时，考虑到区域特征和特定领域的具体要求，一刀切的方法无法达到理想的效果。尊重物种差异、临床环境和当地监管实际情况的针对性策略将带来更好的实施效果和临床影响。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：兽医眼科护理市场：依动物类型划分

  • 猫
  • 牛
  • 狗
  • 马

第九章：兽医眼科护理市场：依产品类型划分

  • 诊断设备
  • 手术器械
  • 治疗药物
    • 抗感染药物
    • 抗发炎药
    • 眼药水润滑剂

第十章：兽医眼科护理市场：依通路划分

  • 线上管道
  • 离线

第十一章 兽医眼科护理市场：依最终使用者划分

  • 研究机构
  • 兽医诊所
  • 动物医院

第十二章 兽医眼科护理市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 兽医眼科护理市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 兽医眼科护理市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国：兽医眼科护理市场

第十六章 中国：兽医眼科护理市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accutome, Inc.
  • An-Vision GmbH
  • Bausch+Lomb Incorporated
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • HEINE Optotechnik GmbH & Co. KG
  • Iridex Corporation
  • I-MED Animal Health
  • Jorgensen Laboratories, LLC
  • LKC Technologies, Inc.
  • Merck & Co., Inc.
  • Occuity Ltd
  • Optomed Plc
  • Reichert, Inc.
  • Revenio Group Oyj
  • Sandoz
  • Zoetis Inc.
Product Code: MRR-B168537792D0

The Veterinary Eye Care Market was valued at USD 5.01 billion in 2025 and is projected to grow to USD 5.37 billion in 2026, with a CAGR of 7.53%, reaching USD 8.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.01 billion
Estimated Year [2026] USD 5.37 billion
Forecast Year [2032] USD 8.34 billion
CAGR (%) 7.53%

A forward-looking introduction to veterinary ophthalmic care that frames clinical evolution, technology adoption, and commercial shifts reshaping practitioner and patient outcomes

The veterinary eye care sector stands at an inflection point driven by converging clinical, technological, and commercial forces. Advances in diagnostic imaging and point-of-care testing have elevated the standard of ocular assessment across companion and production animals, while therapeutic innovation has refined approaches to infection control, inflammation management, and chronic ocular lubrication. At the same time, shifting practice economics and owner expectations are accelerating demand for higher-quality eye care within clinics and hospitals, prompting providers to reassess service mixes and capital allocation.

Practitioners now balance acute surgical interventions with long-term management strategies, and they increasingly rely on integrated diagnostics to inform treatment pathways. Concurrently, manufacturers are adapting product portfolios to align with evolving clinician workflows and regulatory environments. As a result, the ecosystem is moving toward closer collaboration between product developers, distributors, and end users to shorten time-to-adoption and to support evidence-based therapeutic protocols. Looking ahead, sustained improvements in clinical training, coupled with broader access to portable diagnostics, will continue to shape how ocular conditions are detected, triaged, and treated across species and care settings.

A clear summary of the transformative shifts driving veterinary ocular care including diagnostics decentralization, therapeutic targeting, and channel modernization across the ecosystem

The landscape of veterinary eye care has undergone transformative shifts that extend beyond incremental product improvements to encompass new care models and cross-disciplinary collaboration. Diagnostic sophistication has migrated from centralized specialty centers to primary care settings through portable imaging and simplified interpretation tools, enabling earlier detection and less invasive interventions. This transition has fostered a redefinition of clinical roles, with general practitioners increasingly managing conditions once reserved for specialists, thereby altering referral dynamics and service economics.

At the same time, therapeutics are becoming more targeted, driven by advances in formulation science and a clearer understanding of ocular pharmacokinetics across species. These developments are complemented by digital tools that support remote monitoring and tele-ophthalmology consultations, which broaden access while imposing new requirements for data interoperability and clinician training. In parallel, supply chain modernization and omnichannel distribution strategies have reshaped product availability, compelling manufacturers to invest in direct engagement with veterinary networks. Together, these shifts are creating an environment where agility, clinical evidence, and channel alignment determine who captures clinical mindshare and long-term trust among practitioners and animal owners.

An analytical overview of how recent and cumulative tariff measures have reshaped supply resilience, procurement behavior, and cost dynamics within veterinary ophthalmic supply chains

The introduction of tariffs affecting imports linked to ocular devices and active pharmaceutical ingredients has had a cumulative impact on supply chains, pricing dynamics, and procurement strategies within veterinary eye care. Tariff-induced cost pressures have prompted many manufacturers and distributors to reassess sourcing strategies, favoring supplier diversification and enhanced inventory management to mitigate exposure to concentrated trade routes. As a consequence, product lead times and cost-to-clinic for certain diagnostic equipment and specialty therapeutics have shown increased variability, which in turn has influenced purchasing behaviors among clinics and hospitals.

Furthermore, regulatory compliance and customs administration requirements have placed additional operational burdens on smaller suppliers and distributors, encouraging consolidation among logistics partners and fostering partnerships with regional manufacturers that can provide more predictable supply. Clinicians and procurement teams have adapted by prioritizing product portfolios that demonstrate both clinical efficacy and resilient supply pathways. In addition, the tariffs environment has accelerated interest in domestic manufacturing and contract manufacturing options that reduce tariff exposure, while also increasing the emphasis on product standardization to simplify cross-border regulatory approvals. Taken together, these effects have reshaped strategic sourcing, inventory policy, and investment decisions across the veterinary eye care value chain.

A nuanced segmentation analysis that connects animal type, product category, channel preferences, and end-user requirements to reveal differentiated adoption pathways and commercial priorities

Insightful segmentation reveals how demand patterns, product preferences, and distribution practices vary across animal types, product categories, channels, and end-user settings. Cats and dogs dominate demand for clinic-based diagnostics and ophthalmic therapeutics, reflecting high owner willingness to invest in advanced care, whereas cattle and horses drive a distinct set of needs focused on robust, field-ready diagnostics and cost-effective therapeutic regimens suitable for production and performance contexts. In turn, product type segmentation highlights how diagnostics equipment adoption is shaped by the balance between portability and image resolution, how surgical equipment investments reflect clinic case mix and surgical throughput, and how therapeutics-divided into anti infectives, anti inflammatories, and ocular lubricants-are selected based on species-specific pharmacology and administration practicality.

Distribution channel dynamics further influence access and adoption, with direct sales channels enabling close vendor-clinic relationships and technical support, online channels expanding reach for routine consumables, retail pharmacies offering convenience to pet owners, and veterinary distributors providing bundled solutions and inventory services for larger networks. Finally, end-user segmentation across research institutes, veterinary clinics, and veterinary hospitals underscores divergent purchasing rationales: research entities prioritize technical capabilities and reproducibility, clinics focus on cost-effectiveness and workflow integration, and hospitals emphasize comprehensive capability, including advanced surgical suites and in-house diagnostics. Synthesizing these dimensions reveals where manufacturers and channel partners should tailor messaging, training, and product design to align with the operational realities of each segment.

Key regional dynamics that determine adoption velocity, regulatory complexity, and channel effectiveness across the Americas, Europe Middle East & Africa, and Asia-Pacific landscapes

Regional dynamics shape where innovation is adopted first, how regulatory regimes influence product registration, and which distribution models prove most effective. The Americas exhibit strong clinical adoption in companion animal care, supported by established veterinary clinic networks and an emphasis on advanced diagnostics and specialty therapeutics, while supply chain flexibility and mature distributor relationships facilitate rapid product rollouts. In contrast, Europe, Middle East & Africa present a heterogeneous landscape where regulatory variability and fragmented distribution create both challenges and opportunities for regional partners; success in this region hinges on localized regulatory expertise and tailored commercial strategies that respect national practice patterns.

Asia-Pacific stands out for rapid clinics expansion, growing pet ownership, and increasing investment in veterinary education, all of which create fertile ground for portable diagnostics and scalable therapeutic solutions. However, the region also demands localized value propositions, competitive pricing structures, and partnerships with national distributors to navigate diverse regulatory frameworks. Across all regions, strategic entry and scale-up require close attention to local training needs, reimbursement or payment behaviors, and the presence of regional manufacturing or contract production capabilities that can mitigate trade-related volatility. By aligning product positioning and go-to-market models with these regional nuances, manufacturers can optimize uptake and establish durable commercial footprints.

Strategic company-level insights that expose how product innovation, clinical support, and supply resilience drive competitive advantage and partnership-led growth in ophthalmic veterinary care

Competitive dynamics in veterinary eye care are increasingly defined by an intersection of product excellence, service capability, and collaborative partnerships. Leading firms differentiate through investments in diagnostic accuracy, user-centered device ergonomics, and formulations that account for interspecies variation in dosing and tolerability. Beyond product attributes, companies that provide robust clinical education, responsive technical support, and integrated digital resources gain preference among veterinary clinicians who seek both outcomes and ease of use. Strategic partnerships between device manufacturers, pharmaceutical developers, and distribution networks are emerging as critical mechanisms to accelerate adoption and to create bundled care pathways that simplify procurement and clinical workflow.

Mergers, acquisitions, and alliance-building are also shaping capability sets, enabling faster access to complementary technologies and new channels. At the same time, smaller innovators contribute by addressing niche needs-such as field-friendly diagnostics and species-specific therapeutic formulations-that larger players may overlook. Importantly, supply chain resilience and regulatory intelligence have become differentiators; companies that can reliably deliver products with clear compliance documentation and predictable logistics enjoy stronger trust among large hospital networks and procurement partners. For market participants, the combination of clinical validation, localized support, and supply reliability determines which companies secure long-term clinical partnerships.

Actionable strategic recommendations for stakeholders to strengthen clinical engagement, diversify supply chains, and align commercialization for sustained adoption and competitive resilience

Industry leaders seeking to capture value in veterinary eye care should adopt a multi-dimensional strategy that balances product innovation with pragmatic commercialization and operational resilience. First, deepen clinical engagement by investing in translational evidence generation and hands-on training programs that demonstrate clear benefits in diagnostic accuracy, surgical outcomes, and therapeutic adherence. Second, diversify sourcing and logistics to reduce exposure to concentrated trade routes, and consider regional manufacturing or contract production to improve responsiveness and lower cross-border friction. Third, tailor go-to-market approaches by aligning product bundles and pricing with the specific needs of clinics, hospitals, and research institutes, ensuring that offerings match both clinical workflows and procurement cycles.

Additionally, embrace digital tools to support tele-ophthalmology, remote monitoring, and clinician decision support, thereby extending the utility of diagnostic investments and strengthening customer lock-in. Cultivate partnerships across the value chain-linking manufacturers, distributors, and training providers-to deliver bundled solutions that simplify purchasing and shorten learning curves. Finally, prioritize regulatory readiness and post-market surveillance to minimize approval delays and to build credibility with clinicians and buyers. By integrating these elements, industry leaders can create defensible positions that balance short-term commercial wins with sustainable clinical impact.

A transparent explanation of the mixed-methods research approach that integrates practitioner interviews, technical review, and cross-segmentation analysis to deliver actionable intelligence

This research synthesizes primary engagement with clinical practitioners, procurement leaders, and technology providers together with a structured review of peer-reviewed literature, regulatory guidance, and publicly available technical performance data for diagnostic and therapeutic products. Primary inputs included structured interviews conducted across a representative set of clinics and hospitals to capture practitioner workflows, procurement constraints, and adoption barriers, complemented by discussions with distribution partners to assess logistics and channel economics. Secondary research focused on technical validation studies, formulation profiles, and regulatory submissions to ensure product-level insights were grounded in established clinical and technical evidence.

Analytical methods incorporated cross-segmentation triangulation to reconcile perspectives across animal type, product category, distribution channel, and end-user setting, enabling robust insight into where clinical need and commercial opportunity intersect. Scenario analysis was used to evaluate the operational implications of supply chain disruptions and tariff shifts, while qualitative synthesis identified recurring themes that inform strategic recommendations. Throughout the methodology, emphasis was placed on data integrity, respondent confidentiality, and reproducibility of findings, ensuring the report provides decision-useful intelligence for commercial leaders and clinical stakeholders.

A conclusive synthesis highlighting strategic imperatives for aligning innovation, clinical validation, and operational resilience to advance veterinary ocular care outcomes

Veterinary eye care is evolving into a more integrated, evidence-driven discipline where diagnostics, therapeutics, and care delivery models converge to improve outcomes across species. The synthesis of clinical demand, technological progress, and shifting trade dynamics demonstrates that long-term success will favor organizations that invest in clinical validation, channel partnerships, and supply chain resilience. At the same time, regional nuances and segment-specific requirements mean that one-size-fits-all approaches will underperform; targeted strategies that respect species differences, care settings, and local regulatory realities will deliver superior adoption and clinical impact.

In closing, the sector presents tangible opportunities for companies that can harmonize product innovation with pragmatic commercialization and operational robustness. Decision-makers should prioritize initiatives that establish clinical credibility, ensure reliable product availability, and provide measurable benefits to practitioners and owners alike. With deliberate investment in these areas, stakeholders can both elevate standards of ocular care and capture enduring commercial advantage within an increasingly sophisticated veterinary healthcare ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Eye Care Market, by Animal Type

  • 8.1. Cats
  • 8.2. Cattle
  • 8.3. Dogs
  • 8.4. Horses

9. Veterinary Eye Care Market, by Product Type

  • 9.1. Diagnostics Equipment
  • 9.2. Surgical Equipment
  • 9.3. Therapeutics
    • 9.3.1. Anti Infectives
    • 9.3.2. Anti Inflammatories
    • 9.3.3. Ocular Lubricants

10. Veterinary Eye Care Market, by Distribution Channel

  • 10.1. Online Channels
  • 10.2. Offline

11. Veterinary Eye Care Market, by End User

  • 11.1. Research Institutes
  • 11.2. Veterinary Clinics
  • 11.3. Veterinary Hospitals

12. Veterinary Eye Care Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Veterinary Eye Care Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Eye Care Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Veterinary Eye Care Market

16. China Veterinary Eye Care Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accutome, Inc.
  • 17.6. An-Vision GmbH
  • 17.7. Bausch + Lomb Incorporated
  • 17.8. Baxter International, Inc.
  • 17.9. Boehringer Ingelheim International GmbH
  • 17.10. Ceva Sante Animale S.A.
  • 17.11. Dechra Pharmaceuticals PLC
  • 17.12. Elanco Animal Health Incorporated
  • 17.13. HEINE Optotechnik GmbH & Co. KG
  • 17.14. Iridex Corporation
  • 17.15. I-MED Animal Health
  • 17.16. Jorgensen Laboratories, LLC
  • 17.17. LKC Technologies, Inc.
  • 17.18. Merck & Co., Inc.
  • 17.19. Occuity Ltd
  • 17.20. Optomed Plc
  • 17.21. Reichert, Inc.
  • 17.22. Revenio Group Oyj
  • 17.23. Sandoz
  • 17.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY EYE CARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY EYE CARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DIAGNOSTICS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DIAGNOSTICS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DIAGNOSTICS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY SURGICAL EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY SURGICAL EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY SURGICAL EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OCULAR LUBRICANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OCULAR LUBRICANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OCULAR LUBRICANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 112. GCC VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. GCC VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. G7 VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 130. G7 VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. G7 VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NATO VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 136. NATO VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. NATO VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)